Table 3.
Genes predicted to be regulated by IRF1 and IRF7 as identified by IPA analysis in R848- and IFN-α treated PM cells
| R848-induced cells | IFN-α-induced cells | ||
|---|---|---|---|
| IRF1 predicted to be activated (35 genes) (P = 2.23E−26) | IRF7 predicted to be activated (56 genes) (P = 1.26E−31) | IRF1 predicted to be activated (39 genes) (P = 3.23E−29) | IRF7 predicted to be activated (42 genes) (P = 4.44E−41) |
| CXCL1, CCL3, CCL2, CXCL5, S100A8, C3, CXCL3, TLR1, CXCL2, TLR2, CCL5, CXCL11, CCL4, CCL7, CXCL10, CASP4, MYD88, CHIL1, IL1B, ZC3H12A, TNIP1, IL1A, GBP5, OLR1, LYN, C4B, IL27, HCK, NLRP3, IFI202B, CCL12, CXCL13, CLEC7A, TNFAIP3, CD14 | C3, CASP1, CASP4, CASP8, CCL2, CCL5, CCRL2, CD274, CD40, CD86, CMPK2, CXCL10, CXCL11, CXCL9, EIF2AK2, FAM26F, FCGR1A, FGL2, GBP2, GBP3, GBP5, GBP6, HERC6, ICAM1, IFI16, IFI35, IFI47, IFIT1, IFIT1B, IFIT2, IFITM3, IGTP, IL15, IL15RA, IL1R1, IL6, ISG15, KLRK1, MX1/MX2, OAS1, OASL, PTGS2, RSAD2, SLFN1, SLFN13, SLFN2, SLFN5, SP110, TAP1, TGTP1, TGTP2, TLR9, TNF, TNFSF10, TRAFD1, USP18 | CASP1, CCL5, CCL7, CD14, CD40, CEBPB, CEBPD, CLIC4, CXCL10, DTX2, FCGR2, GBP5, GCH1, GFAP, IFI47, IKB, IL12B, IL1B, IRAK2, LCN2, LILRB4, NLRP3, NOS2, MAPK, PLSCR1, PRKAA, PSME2, SERCA, SLC16A10, SLFN2, SPATA13, SUSD6, TANK, TNFA, TNFAIP2, TNFAIP3, TNFSF15, TNIP1, TRIP10 | APOBEC3, LY86, TLR2, TLR3, TLR7, TLR9, ISG20, NLRC5, NOD2, TMEM173, CASP4, MYD88, NOD1, OASL2, OASL1, MX1, MX2, LYN, BST2, IFI202B, OAS1B, RIPK2, OAS1A, RNF135, EIF2AK2, IFIH1, C3, CSF1, IFITM3, PML, KLRK1, OAS3, RSAD2, SP110, OAS2, NAIP6, IRGM1, TRIM25, AIM2, DDX58, IFIT3, TRIM56, IFIT2, IFIT1 |